|

PF-07934040 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: PF-4040

Pipeline

Phase 1: 1

Top Sponsors

  • Pfizer1

Indications

  • Carcinoma, Pancreatic Ductal1
  • Carcinoma, Non-Small-Cell Lung1
  • Colorectal Neoplasms1
  • Lung Cancer1
  • Cancer1

Fayetteville, Arkansas1 trial

A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.

Highlands Oncology Group, PA

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.